Search
for
Sort by
Research 421–450 of 1000+
- Increase in IL-15 levels in patients with alopecia areata
- The Safety and Efficacy of Tofacitinib in 24 Cases of Pediatric Rheumatic Diseases: Single Centre Experience
- JAK1 gain-of-function variant causes alopecia areata, atopic dermatitis, and autoimmune thyroid disease
- Role of janus kinase inhibitors in the treatment of alopecia areata
- Real‐world experience and long‐term evaluation of tofacitinib in refractory alopecia areata: A prospective, open‐label, single‐center study in Asian Arab population
- Delayed granulomatous eruption of the nose associated with ruxolitinib
- A review of Janus kinase inhibitor use in scarring alopecia
- Review of efficacy of baricitinib in the treatment of alopecia areata
- Use of oral Janus kinase inhibitors for the treatment of severe alopecia areata: narrative review and real-world experience
- Review of Promising Off-Label Use of Deucravacitinib
- Baricitinib Effectiveness in JAKi‐Naïve and Tofacitinib‐Exposed Patients: A Prospective Study in Alopecia Areata
- Exploring novel management options for alopecia areata
- The role of Janus kinase inhibitors in the treatment of alopecia areata: A systematic review
- Janus kinase inhibitors for alopecia areata: A narrative review
- Ritlecitinib for the Management of Alopecia Areata: A Narrative Review of Real-World Evidence and Selected Post Hoc Analyses
- Systemic Inflammation Marker Alterations in Severe Alopecia Areata Patients Treated with Janus Kinase Inhibitors
- Exosome-Based Therapies for Alopecia Areata: A Systematic Review of Clinical and Experimental Evidence
- A systematic review of tumor necrosis factor-α blockers, anti-interleukins, and small molecule inhibitors for dissecting cellulitis of the scalp treatment
- Citrullination at the Inflammatory Skin Barrier
- Pathomechanisms of immune-mediated alopecia
- Efficacy of Janus Kinase Inhibitors in Alopecia in Jordanian Patients: A Retrospective Cohort Study
- T <sub>H</sub> 1 effector CD4 T cells rely on IFN-γ production to induce alopecia areata
- Alopecia Areata – Effects of Treatment with Upadacitinib – Two Case Reports
- Baricitinib: A Review in Severe Alopecia Areata
- Perspectives of Chinese Adult Patients with Alopecia Areata on Janus Kinase Inhibitors Therapy: A Qualitative Analysis Based on Social Media Platforms
- Systemic Tofacitinib Treatment in Pediatric Patients with Resistant Alopecia Areata
- Resident Memory T Cells in Autoimmune Skin Diseases
- Tofacitinib (Selective Janus Kinase Inhibitor 1 and 3): A promising therapy for the treatment of alopecia areata: A case report of six patients
- Immunopathology and Immunotherapy of Inflammatory Skin Diseases
- The Possible Role of Antibodies in Alopecia: A Narrative Review